Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized phase 3 trial of darunavir/ritonavir + tenofovir/emtricitabine versus darunavir/ritonavir + raltegravir in treatment-naive adults with HIV-1
NL-OMON36340Phase 3Active, not recruiting
- Sponsor
- ANRS
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Darunavir/ritonavir + tenofovir/emtricitabine with Darunavir/ritonavir + raltegravir (2 arms). Started Feb 2011; status: active, not recruiting.
02
Drugs
darunavirritonavirtenofoviremtricitabineraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON36340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36340.